Developing mab Therapies From Tumor Neoantigens

Time: 12:30 pm
day: Day Two

Details:

• Monoclonal abs from Tumor antigens were charactered for specificity and antitumor function
• Identity of neo-epitopes were characterized
• Antibody functions were characterized for clinical trial development